Could a Six-Month Course of Pegylated Interferon-α2a and Ribavirin for Hepatitis Virus C Trigger Sarcoidosis? A Case Report and Literature Review

  • September 2010,
  • cmr.2010.886;
  • DOI: https://doi.org/10.3121/cmr.2010.886

Abstract

Sarcoidosis is a chronic inflammatory multisystem disease of unknown etiology. We report on a 57-year-old woman presenting with typical sarcoidosis occurring two months after completion of a six-month course of interferon-α (IFN-α) and ribavirin for chronic hepatitis C virus (CHC) infection. The current observation is interesting with regard to the time elapsed between symptoms occurrence and antiviral treatment withdrawal and spontaneous recovery after ten months of follow-up. Pathophysiological mechanisms involved in the development of antiviral therapy-induced sarcoidosis are discussed in the present article.

  • Received September 14, 2009.
  • Revision received February 5, 2010.
  • Accepted February 10, 2010.
Loading
  • Share
  • Bookmark this Article